Flu Activity in the U.S. Shows Consecutive Declines Amid Ongoing Respiratory Virus Circulation
January 16, 2026
News & Politics

Flu Activity in the U.S. Shows Consecutive Declines Amid Ongoing Respiratory Virus Circulation

CDC Reports Decrease in Flu Hospitalizations and Office Visits, While Officials Caution Against Early Optimism

Summary

Recent data from the Centers for Disease Control and Prevention (CDC) indicates a decline in flu activity across the United States for the second consecutive week. This trend includes a substantial reduction in hospitalizations and a noticeable drop in medical office visits for flu-like symptoms. Despite these improvements, experts warn that the flu season is not yet over, especially with the potential for a resurgence following the winter holidays, compounded by the predominance of a challenging viral strain this year.

Key Points

The CDC reports a continuous decline in U.S. flu activity over two weeks, with significant decreases in hospitalizations and medical office visits for flu-like symptoms.
A reduction in the number of states experiencing high flu activity has been observed, falling from 44 to 36 states.
The dominant influenza strain this season is the A H3N2 subtype, particularly a new variant not well covered by the current flu vaccine, historically linked to high hospitalization and death rates among older individuals.

Updated surveillance from the Centers for Disease Control and Prevention (CDC) reveals that indicators of influenza activity in the United States have decreased for the second straight week. The agency's most recent report, covering data through last week, highlights a significant reduction in hospital admissions related to the flu and a lower, yet meaningful, decline in visits to healthcare providers for influenza-like illness.

Moreover, the number of states classified as experiencing high flu activity has dropped from 44 to 36, suggesting a broader national easing of flu virus transmission. Concurrently, other respiratory illnesses common to the winter months, including COVID-19 and respiratory syncytial virus (RSV), have not exhibited any major outbreak surges in recent reporting.

Health authorities characterize the ongoing respiratory virus season as "moderate." Nevertheless, this designation should not be interpreted as signaling the conclusion of the flu season. Experts stress that it is not uncommon for a second wave of influenza cases to emerge following the holiday period.

Dr. William Schaffner, a specialist in infectious diseases at Vanderbilt University, commented on the current situation, stating, "We have observed past seasons where after an initial peak, flu activity has subsided only to persist for a prolonged time." He further noted that while many hope for a swift end to this year’s flu waves, reliance on early signs of decline remains uncertain.

The ongoing flu season has presented particular challenges due to the dominance of the A H3N2 influenza virus subtype. This strain is historically associated with the highest rates of hospitalization and mortality among older adult populations. Alarmingly, about 90% of the H3N2 viral samples analyzed during this season correspond to a novel strain that diverges from the variant included in the current year’s influenza vaccination formulations.

To date, CDC estimates for the season include at least 18 million flu illnesses, approximately 230,000 hospital admissions, and an estimated 9,300 deaths attributable to influenza. Among mortality statistics, at least 32 children have died. Notably, of the pediatric cases where vaccination status is documented, 90% of these children were not fully immunized against the flu.

Risks
  • Potential for a second increase in flu cases following the winter holiday period, as has been observed in prior seasons, which could strain healthcare systems.
  • Reduced vaccine effectiveness against the circulating new H3N2 flu strain may increase hospitalizations and mortality, particularly among vulnerable older populations.
  • A significant portion of children who succumbed to the flu were not fully vaccinated, highlighting the risk posed by suboptimal immunization coverage in pediatric populations.
Disclosure
This article is independently produced with no commercial influence. All information is based on official CDC data and statements from healthcare experts.
Search Articles
Category
News & Politics

News & Politics

Related Articles
UnitedHealth After the Collapse - A Structured Long Trade With Defined Risk

UnitedHealth (UNH) has fallen roughly 50% from its mid-2025 highs and now trades near $273 (as of 02...

Oscar Health Targets Profitability in 2026 Following Challenging 2025

Oscar Health Inc. reported fourth-quarter revenue growth driven by expanding membership but faced in...

Becton Dickinson Faces Market Headwinds Amid Transition and Revised Earnings Projections

Becton Dickinson & Co. posted first-quarter earnings above analyst expectations but trimmed its fisc...

Quest Diagnostics Reports Strong Q4 Earnings and Raises Full-Year Guidance Driving Stock Higher

Quest Diagnostics posted fourth-quarter results surpassing both earnings and revenue expectations, d...

UBS Adjusts Tech Sector Outlook, Advocates Diversification Into Healthcare and Financials

UBS has revised its stance on the U.S. information technology sector from attractive to neutral, hig...

Encompass Health: Buy the Franchise, Manage the Legal Noise

Encompass Health (EHC) combines durable operating cash flow, steady revenue (~$5.9B in FY2025) and a...